Drugs / (NORTH)-METHANOCARBATHYMIDINE
(NORTH)-METHANOCARBATHYMIDINE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02778386 | Apr → Dec 2016 | poisoning | N&N Pharmaceuticals Inc. | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | (NORTH)-METHANOCARBATHYMIDINE | ChEMBL registry synonym — accepted as the source's own label CHEMBL146673 ↗ |
| Known as | N-mct | ChEMBL registry synonym — accepted as the source's own label CHEMBL146673 ↗ |
| Known as | N-Methanocarbathymidine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02778386 ↗ |
| Modality | Small molecule | — CHEMBL146673 ↗ |
| Route | Oral | “N-Methanocarbathymidine administered orally” NCT02778386 ↗ |